Evoq Therapeutics is a seed startup. 1 investor tracked. Status: possibledead.
Evoq Therapeutics is a company founded in 2018 headquartered in the United States. Its most recent tracked round is Seed. Brouky records 1 investor associated with the company.
Evoq Therapeutics develops immunotherapies using its proprietary NanoDisc technology to restore immune tolerance in patients with autoimmune diseases such as Type 1 diabetes, Celiac disease, and Lupus.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.